| Date Filed | Type | Description |
| 01/09/2023 |
4
| Perkins Adelene Q (Director) has filed a Form 4 on BRUKER CORP|
Txns:
| Granted 1,970 shares
@ $0 |
|
| 01/12/2022 |
4
| Perkins Adelene Q (CEO) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 576,100 options to buy
@ $1.53, valued at
$881.4k
|
|
| 01/06/2022 |
4
| Perkins Adelene Q (Director) has filed a Form 4 on BRUKER CORP|
Txns:
| Granted 1,841 shares
@ $0 |
|
| 01/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2020 |
4
| Perkins Adelene Q (CEO) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 485,000 options to buy
@ $2.14, valued at
$1M
|
|
| 01/13/2020 |
4
| Perkins Adelene Q (CEO) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 155,134 shares
@ $0
Granted 606,250 options to buy
@ $1.25, valued at
$757.8k
|
|
| 01/07/2020 |
4
| Perkins Adelene Q (Director) has filed a Form 4 on BRUKER CORP|
Txns:
| Granted 2,472 shares
@ $0 |
|
| 06/14/2019 |
4
| Perkins Adelene Q (CEO) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 242,000 options to buy
@ $1.24, valued at
$300.1k
|
|
| 01/10/2019 |
4
| Perkins Adelene Q (Director) has filed a Form 4 on BRUKER CORP|
Txns:
| Granted 4,134 shares
@ $0 |
|
| 01/07/2019 |
4
| Perkins Adelene Q (CEO) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 243,000 options to buy
@ $1.24, valued at
$301.3k
|
|
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2018 |
4
| Perkins Adelene Q (CEO) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Sold 5,000 shares
@ $2.778, valued at
$13.9k
|
|
| 01/09/2018 |
4
| Perkins Adelene Q (CEO) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 500,000 options to buy
@ $1.985, valued at
$992.5k
|
|
| 01/09/2018 |
4
| Perkins Adelene Q (Director) has filed a Form 4 on BRUKER CORP|
Txns:
| Granted 3,474 shares
@ $0 |
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/25/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 04/14/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 01/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/02/2016 |
4
| Perkins Adelene Q (President & CEO) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 85,800 shares
@ $0 |
|
| 01/08/2016 |
4
| Perkins Adelene Q (President & CEO) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 185,000 options to buy
@ $6.71, valued at
$1.2M
|
|
| 06/26/2015 |
4
| Perkins Adelene Q (President & CEO) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Sold 5,000 shares
@ $10.93, valued at
$54.7k
|
|
| 05/28/2015 |
4
| Perkins Adelene Q (President & CEO) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Sold 10,000 shares
@ $12.81, valued at
$128.1k
|
|
| 05/15/2015 |
4
| Perkins Adelene Q (President & CEO) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Sold 10,000 shares
@ $12.18, valued at
$121.8k
|
|
| 03/17/2015 |
4
| Perkins Adelene Q (President & CEO) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Sold 20,000 shares
@ $16, valued at
$320k
|
|
| 03/09/2015 |
4
| Perkins Adelene Q (President & CEO) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Sold 25,000 shares
@ $16.5, valued at
$412.5k
|
|
| 03/09/2015 |
4/A
| Perkins Adelene Q (President & CEO) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Sold 20,000 shares
@ $14.8268, valued at
$296.5k
|
|
| 02/02/2015 |
4
| Perkins Adelene Q (President & CEO) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Sold 20,000 shares
@ $14.8268, valued at
$296.5k
|
|
| 01/16/2015 |
4
| Perkins Adelene Q (President & CEO) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 250,000 options to buy
@ $15.74, valued at
$3.9M
|
|
| 01/14/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/13/2013 |
4
| Perkins Adelene Q (Pres & CEO) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Sold 31,924 shares
@ $20.8116, valued at
$664.4k
Sold 13,076 shares
@ $20.5029, valued at
$268.1k
|
|
| 01/08/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/09/2012 |
4
| Perkins Adelene Q (See Remarks) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 191,750 options to buy
@ $7.93, valued at
$1.5M
|
|
|